Medical history (history of illness) represents an important component in the diagnosis of weight gain. Family history
- Are there any diseases in your family that are common?
- What is the general health of your family members?
Social anamnesis
Current medical history/systemic medical history (somatic and psychological complaints).
- How much body weight have you gained in the past six months? Was the weight gain intentional?
- How quickly did you gain the weight?
- Did you eat normally (usual amounts and composition)? Or did you eat more or less than before?
- Since gaining weight, do you feel unable to perform (performance slump)?
- Have you noticed other symptoms such as fatigue or fever?
- Do you have increased abdominal pain, constipation, etc.?
- Are you currently suffering from an infection?
- Do you suffer from problems falling asleep or sleeping through?
- Do you currently have increased stress / mental stress?
Vegetative anamnesis incl. nutritional anamnesis.
- Are you overweight? Please tell us your body weight (in kg) and height (in cm).
- What are your eating habits? (Food history including hunger pangs).
- Has your digestion changed? Do you have frequent diarrhea or constipation?
- Has your urinary output changed?
- Do you drink alcohol? If so, what drink(s) and how many per day?
- Do you smoke? If yes, how many cigarettes, cigars or pipes per day?
- Do you use drugs? If yes, what drugs and how often per day or per week?
Self history incl. medication history.
- Pre-existing conditions
- Operations
- Allergies
- For women: Number of pregnancies/births
- Medication history
Medication history
- Antidepressants
- Monoamine oxidase inhibitors (MAO inhibitors) – moclobemide
- Noradrenergic and specific serotonergic antidepressants (NaSSA) – mirtazapine (moderate).
- Selective serotonin–norepinephrine reuptake inhibitors (SSNRIs) – duloxetine (moderate), venlafaxine (moderate).
- Selective serotonin reuptake inhibitors (SSRI) – citalopram (moderate), escitalopram (moderate), fluoxetine (low), fluvoxamine, paroxetine (moderate), sertraline (moderate).
- Tetracyclic antidepressants (maprotiline, mianserine).
- Tricyclic antidepressants (TCAs) – amitriptyline, clomipramine, doxepin, imipramine, nortriptyline, opipramol, trimipramine.
- Antiepileptic drugs
- AMPA receptor antagonist (perampanel).
- KCNQ2/3 opener (retigabine).
- Classical antiepileptic drugs (valproate).
- Antihistamines (ketotifen).
- Antipsychotics (neuroleptics)
- Amisulpride, aripiprazole, clozapine, haloperidol, melperone, olanzapine (strong), quetiapine, risperidone (moderate), ziprasidone (low), zuclopenthixol.
- Alimemazine, chlorpromazine (strong), perphenazine, promethazine (moderate), promazine (light), thioridazine, triflupromazine
- Hormones
- Anabolic steroids (strong)
- Androgens: testosterone and androstenedione (medium).
- Cortisol and its derivatives (strong)
- Progestogens (chlormadinone acetate, cyproterone acetate, desogestrel, dienogest, drospirenone, gestodene, levonorgestrel, norethisterone, norgestimate, nomegestrol) (very low).
- GnRH analogues (goserelin acetate, leuporelin acetate, buderelin acetate, nafarelin acetate, triptorelin acetate).
- Insulin (strong)
- Contraceptives: ethinyl estradiol (low).
- Estrogens, except ethinyl estradiol (very low).
- Pizotifen
- Phase prophylactics
- Lithium, valproate (strong), carbamzepine (moderate), gabapentin, lamotrigine, topiramate (low).
- Other pharmaceuticals with adipogenic effects
- Alpha-2 agonists (α2-adrenoceptor agonists) (very low) such as midodrine.
- Beta-blockers (low): nonselective beta-blockers (eg, carvedilol, propranolol, soltalol) [inhibition of insulin secretion; more potent than selective beta-blockers]; selective beta-blockers (eg, atenolol, bisoprolol, metoprolol)
- Glinides (nateglinide, repaglinide).
- Glitazones (thiazolidinediones: pioglitazone, rosiglitazone).
- Sulfonylureas (medium) (glibenclamide, gliclazide, glimepiride, gliquidone, tolbutamide).
- Thiazolidinediones (low) such as rosiglitazone.
